-- 加拿大皇家銀行資本市場（RBC Capital Markets）週四表示，星巴克（SBUX）近期同店銷售額受益於近期的勞動力投資、門市關閉和延長營業時間，但這些利好因素在2027年完全顯現後，北美地區同店銷售額能否維持在個位數中段水平仍存在爭議。 RBC將北美同店銷售額成長預期上調至5%，比華爾街普遍預期的3.9%高出114個基點。 RBC在報告中指出，雖然其第二季營收預期僅略低於市場普遍預期，但息稅前利潤（EBIT）和每股盈餘（EPS）預期分別比市場普遍預期低4.3%和6.0%，原因是市場對年比利潤率成長的預期過於樂觀。 RBC表示，同店銷售額的成長推動其第二季營收和每股盈餘預期分別上調1.3%和8.3%。該券商也將北美第三季同店銷售額成長預期上修100個基點至5%，並將第四季預期從4.5%下調至4%。 根據報告，RBC下調了對星巴克下半年及以後的獲利預期，以反映出售中國業務的影響。 RBC維持對星巴克「與業界持平」的評級，目標價為105美元。
Price: $101.12, Change: $+2.76, Percent Change: +2.81%
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.